Vivo Opportunity Fund Holdings, L.P. - Jun 30, 2025 SCHEDULE 13G/A Report for Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share (SLNO)

Filing Manager: Vivo Opportunity Fund Holdings, L.P.
Reporting Manager: Vivo Opportunity Fund Holdings, L.P.
Security: Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: SLNO
Shares outstanding: 53.5M shares
Disclosed Ownership: 3.96M shares
Ownership: 7.4%
Form type: SCHEDULE 13G/A
Date filed: 8/12/2025, 08:52 PM
Date of event: Jun 30, 2025
Previous filing: Mar 31, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vivo Opportunity Fund Holdings, L.P.	7.4%	3.96M	3.96M	0	/s/ Kevin Dai	Kevin Dai/Managing Member
Vivo Opportunity, LLC	7.4%	3.96M	3.96M	0	/s/ Kevin Dai	Kevin Dai/Managing Member